A detailed history of Principal Financial Group Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Principal Financial Group Inc holds 2,010,441 shares of BSX stock, worth $182 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,010,441
Previous 1,898,717 5.88%
Holding current value
$182 Million
Previous $146 Million 15.22%
% of portfolio
0.1%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$72.96 - $84.0 $8.15 Million - $9.38 Million
111,724 Added 5.88%
2,010,441 $168 Million
Q2 2024

Jul 29, 2024

SELL
$67.33 - $77.71 $2.18 Million - $2.52 Million
-32,366 Reduced 1.68%
1,898,717 $146 Million
Q1 2024

Apr 29, 2024

BUY
$57.6 - $68.62 $2.73 Million - $3.26 Million
47,480 Added 2.52%
1,931,083 $132 Million
Q4 2023

Feb 07, 2024

BUY
$48.64 - $57.81 $710,727 - $844,719
14,612 Added 0.78%
1,883,603 $109 Million
Q3 2023

Nov 02, 2023

BUY
$50.19 - $54.68 $1.92 Million - $2.09 Million
38,249 Added 2.09%
1,868,991 $98.7 Million
Q2 2023

Aug 07, 2023

SELL
$49.72 - $54.64 $2.19 Million - $2.41 Million
-44,076 Reduced 2.35%
1,830,742 $99 Million
Q1 2023

May 09, 2023

BUY
$45.09 - $50.03 $11.7 Million - $13 Million
259,015 Added 16.03%
1,874,818 $93.8 Million
Q4 2022

Feb 09, 2023

SELL
$39.56 - $47.22 $1.69 Million - $2.01 Million
-42,672 Reduced 2.57%
1,615,803 $74.8 Million
Q3 2022

Nov 09, 2022

SELL
$36.71 - $109.66 $1.12 Million - $3.35 Million
-30,523 Reduced 1.81%
1,658,475 $64.2 Million
Q2 2022

Aug 10, 2022

BUY
$35.24 - $47.1 $1.02 Million - $1.36 Million
28,879 Added 1.74%
1,688,998 $62.9 Million
Q1 2022

May 09, 2022

SELL
$40.9 - $45.1 $599,103 - $660,624
-14,648 Reduced 0.87%
1,660,119 $73.5 Million
Q4 2021

Feb 09, 2022

SELL
$38.07 - $44.87 $1.31 Million - $1.55 Million
-34,495 Reduced 2.02%
1,674,767 $71.1 Million
Q3 2021

Nov 09, 2021

BUY
$41.23 - $45.88 $36,612 - $40,741
888 Added 0.05%
1,709,262 $74.2 Million
Q2 2021

Aug 10, 2021

BUY
$38.58 - $44.24 $1.26 Million - $1.45 Million
32,728 Added 1.95%
1,708,374 $73.1 Million
Q1 2021

May 10, 2021

SELL
$35.27 - $39.67 $11.3 Million - $12.7 Million
-319,573 Reduced 16.02%
1,675,646 $64.8 Million
Q4 2020

Feb 08, 2021

BUY
$33.15 - $41.97 $1.87 Million - $2.36 Million
56,327 Added 2.91%
1,995,219 $71.7 Million
Q3 2020

Nov 06, 2020

SELL
$34.44 - $42.23 $3.5 Million - $4.29 Million
-101,607 Reduced 4.98%
1,938,892 $74.1 Million
Q2 2020

Aug 05, 2020

BUY
$30.19 - $39.11 $2.19 Million - $2.84 Million
72,663 Added 3.69%
2,040,499 $71.6 Million
Q1 2020

May 12, 2020

BUY
$25.83 - $45.71 $40,294 - $71,307
1,560 Added 0.08%
1,967,836 $64.2 Million
Q4 2019

Feb 05, 2020

SELL
$37.87 - $45.37 $2 Million - $2.39 Million
-52,736 Reduced 2.61%
1,966,276 $88.9 Million
Q3 2019

Nov 13, 2019

SELL
$40.31 - $43.45 $311,797 - $336,085
-7,735 Reduced 0.38%
2,019,012 $82.2 Million
Q2 2019

Aug 12, 2019

BUY
$34.91 - $42.98 $746,655 - $919,256
21,388 Added 1.07%
2,026,747 $87.1 Million
Q1 2019

May 10, 2019

SELL
$32.91 - $40.75 $350,392 - $433,865
-10,647 Reduced 0.53%
2,005,359 $77 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $660,777 - $813,008
-20,825 Reduced 1.02%
2,016,006 $71.2 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $977,053 - $1.15 Million
29,761 Added 1.48%
2,036,831 $78.4 Million
Q2 2018

Aug 13, 2018

BUY
$26.84 - $34.32 $301,520 - $385,550
11,234 Added 0.56%
2,007,070 $0
Q1 2018

May 14, 2018

SELL
$25.2 - $28.54 $286,650 - $324,642
-11,375 Reduced 0.57%
1,995,836 $54.5 Million
Q4 2017

Feb 13, 2018

BUY
$24.79 - $29.8 $864,675 - $1.04 Million
34,880 Added 1.77%
2,007,211 $49.8 Million
Q3 2017

Nov 02, 2017

BUY
$26.26 - $29.17 $51.8 Million - $57.5 Million
1,972,331
1,972,331 $57.5 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.